The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(1R,5aS,6R,9aS)-1-(hydroxymethyl)-1,5a-dimethyl-7-methylene-6-((E)-2-(2-oxo-2,5-dihydrofuran-3-yl)ethenyl)octahydro-1H-benzo[c]azepin-3(2H)-one ID: ALA4476790
PubChem CID: 155538663
Max Phase: Preclinical
Molecular Formula: C20H27NO4
Molecular Weight: 345.44
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C=C1CC[C@H]2[C@@](C)(CCC(=O)N[C@@]2(C)CO)[C@@H]1/C=C/C1=CCOC1=O
Standard InChI: InChI=1S/C20H27NO4/c1-13-4-7-16-19(2,10-8-17(23)21-20(16,3)12-22)15(13)6-5-14-9-11-25-18(14)24/h5-6,9,15-16,22H,1,4,7-8,10-12H2,2-3H3,(H,21,23)/b6-5+/t15-,16+,19+,20+/m1/s1
Standard InChI Key: KMWVVYHGNIPQHR-WHCBKWPTSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
3.7833 -7.0791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2000 -6.4957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9864 -7.2926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5619 -6.3874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2740 -5.9791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2740 -5.1541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5619 -4.7375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8520 -5.1532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8500 -5.9791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2020 -4.6347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3918 -6.3175 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3919 -4.8204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0342 -5.5702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5802 -6.8656 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0624 -6.7750 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
1.2092 -5.5706 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8458 -4.3250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5618 -3.9125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2762 -3.4998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2761 -2.6748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9398 -2.1870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6846 -1.4024 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8596 -1.4026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6049 -2.1872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7251 -2.4397 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9896 -4.7437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8 7 1 0
9 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
8 9 1 0
9 2 1 0
8 10 1 0
2 11 1 0
10 12 1 0
11 13 1 0
12 13 1 0
2 1 1 0
2 3 1 1
1 14 1 0
9 15 1 1
13 16 2 0
8 17 1 6
7 18 1 6
18 19 2 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 20 2 0
21 25 2 0
6 26 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 345.44Molecular Weight (Monoisotopic): 345.1940AlogP: 2.28#Rotatable Bonds: 3Polar Surface Area: 75.63Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.97CX Basic pKa: ┄CX LogP: 1.67CX LogD: 1.67Aromatic Rings: ┄Heavy Atoms: 25QED Weighted: 0.61Np Likeness Score: 2.86
References 1. Wang W, Wu Y, Yang K, Wu C, Tang R, Li H, Chen L.. (2019) Synthesis of novel andrographolide beckmann rearrangement derivatives and evaluation of their HK2-related anti-inflammatory activities., 173 [PMID:31009914 ] [10.1016/j.ejmech.2019.04.022 ]